It has been demonstrated that sodium orthovanadate (vanadate) through the epidermal growth factor receptor (EGFR) pathway can overcome tumor resistance to these viruses and improve the antitumor effects of RNA‐based oncolytic viruses in a synergistic fashion.[62]. The gene discussed is EGFR; the disease is neoplasm.